FBRX_OUT_1 [2025-03-25 11:04:10 -0400] 1952 Bytes | 578 tokens | Cum: 578 tkns (7.22% of 8k)
==========================================================================

We are in the 'Lightning Round' baby! It's 11:04:09 AM on Tue Mar 25, 2025 -0400, and I'm firing up the spotlight on Forte Biosciences (FBRX), moving from 6.32 to 7.75. Is this a can’t-miss rocket or a one-hit wonder? Let’s dissect the numbers!

Here's the first list of news for Forte Biosciences:

C1 - Feb-03-25 09:00AM - Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
C2 - Nov-25-24 09:00AM - Forte Biosciences to Host RandD Day December 3, 2024
C3 - Nov-25-24 09:00AM 09:00AM - Forte Biosciences to Host R&D Day December 3, 2024
C4 - Nov-20-24 09:00AM - Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
C5 - Nov-14-24 04:01PM - Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update
C6 - Aug-26-24 11:51AM - Upcoming Stock Splits This Week (August 26 to August 30) Stay Invested
C7 - Aug-14-24 09:54PM - FBRX Stock Earnings: Forte Biosciences Misses EPS for Q2 2024
C8 - Aug-14-24 09:54PM 04:01PM - Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Forte Biosciences (FBRX)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

FBRX_OUT_3 [2025-03-25 11:04:17 -0400] 552 Bytes | 149 tokens | Cum: 729 tkns (9.11% of 8k)
==========================================================================

Showing C4 (chunk 1 of 1): C4:
**Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications**
Date: Nov-20-24 09:00AM
Source: (Business Wire)
URL: https://www.businesswire.com/news/home/20241120549128/en/

Error fetching article: 403 Client Error: Forbidden for url: https://www.businesswire.com/news/home/20241120549128/en/

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

FBRX_OUT_5 [2025-03-25 11:04:18 -0400] 591 Bytes | 160 tokens | Cum: 971 tkns (12.14% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-21T10:49:49Z - North American Morning Briefing : Stock Futures Fall as Focus Shifts From Fed to Tariffs...
A2 - 2025-02-28T21:25:23Z - Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Update...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

FBRX_OUT_7 [2025-03-25 11:04:20 -0400] 1039 Bytes | 276 tokens | Cum: 1249 tkns (15.61% of 8k)
==========================================================================

Showing A1 (chunk 1 of 11): A1:
**North American Morning Briefing : Stock Futures Fall as Focus Shifts From Fed to Tariffs**Date: 2025-03-21Source: {'uri': 'marketscreener.com', 'dataType': 'news', 'title': 'Market Screener'}URL: https://www.marketscreener.com/quote/currency/EURO-US-DOLLAR-EUR-USD-4591/news/North-American-Morning-Briefing-Stock-Futures-Fall-as-Focus-Shifts-From-Fed-to-Tariffs-49398576/The euphoria from the Federal Reserve's policy meeting didn't last long.

Stock futures were lower Friday as attention shifted from the Fed to the prospect of further tariffs.

Trump said in a social media post that the planned imposition of reciprocal tariffs on April 2 would be "Liberation Day" in the U.S.

"We maintain our view that the FOMC outcome was effectively a one-day move, with minimal legacy in terms of immediate direction. That said, we also view the FOMC outcome as a whole as nodding towards dovishness,

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

FBRX_OUT_9 [2025-03-25 11:04:21 -0400] 788 Bytes | 264 tokens | Cum: 1515 tkns (18.94% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-03-25T16:00:10Z - What Makes Forte Biosciences (FBRX) a New Buy Stock
B2 - 2023-12-13T13:29:24Z - Research Frontiers And 3 Other Stocks Under $1 Insiders Are Buying
B3 - 2023-12-11T13:34:01Z - RiskOn International And 3 Other Stocks Under $2 Insiders Are Buying
B4 - 2023-11-24T11:38:00Z - Insiders Buying Vintage Wine Estates And 3 Other Stocks Under $1
B5 - 2023-04-06T19:53:22Z - Penny Stocks To Buy Now? 4 To Watch In April
B6 - 2022-07-13T08:59:07Z - Boeing, PriceSmart And 80 Biggest Movers From Yesterday

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

FBRX_OUT_11 [2025-03-25 11:04:25 -0400] 486 Bytes | 143 tokens | Cum: 1660 tkns (20.75% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**What Makes Forte Biosciences (FBRX) a New Buy Stock**Date: Unknown DateSource: Unknown SourceURL: https://www.zacks.com/stock/news/2245625/what-makes-forte-biosciences-fbrx-a-new-buy-stockForte Biosciences (FBRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

FBRX_OUT_13 [2025-03-25 11:04:27 -0400] 238 Bytes | 59 tokens | Cum: 1770 tkns (22.12% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

FBRX_OUT_15 [2025-03-25 11:04:46 -0400] 5821 Bytes | 1759 tokens | Cum: 3532 tkns (44.15% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+--------------------+-----------------------+----------------------+------------------------+----------------------+----------------------+
| Volume: 30,497 | SMA50: -30.62% | Market Cap: 48.34M | Option/Short: No / Yes | Sales past 5Y: 0.00% | Sales Surprise: - |
+--------------------+-----------------------+----------------------+------------------------+----------------------+----------------------+
| Avg Volume: 40.95K | SMA200: -34.50% | Shs Outstand: 6.39M | Short Float: 0.24% | Employees: 9 | EPS Surprise: 28.32% |
+--------------------+-----------------------+----------------------+------------------------+----------------------+----------------------+
| Rel Volume: 3.07 | Perf Week: 37.45% | Shs Float: 5.17M | Short Ratio: 0.30 | Debt/Eq: 0.00 | P/E: - |
+--------------------+-----------------------+----------------------+------------------------+----------------------+----------------------+
| RSI (14): 46.05 | Perf Month: -21.66% | Inst Own: 69.10% | Short Interest: 0.01M | Sales Y/Y TTM: - | Earnings: Nov 14 AMC |
+--------------------+-----------------------+----------------------+------------------------+----------------------+----------------------+
| ATR (14): 1.33 | Perf Quarter: -59.49% | Insider Own: 19.14% | Beta: 2.60 | ROE: -137.40% | |
+--------------------+-----------------------+----------------------+------------------------+----------------------+----------------------+
| SMA20: 8.12% | Index: - | Insider Trans: 1.87% | Sales Q/Q: - | ROI: -365.10% | |
+--------------------+-----------------------+----------------------+------------------------+----------------------+----------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

Inside Trans: Forte Biosciences, Inc. (FBRX) by FINCK BARBARA K (Unknown Title) on 2025-03-19
- Stock Option (right to buy): 31000 shares at $0 (D)

Inside Trans: Forte Biosciences, Inc. (FBRX) by Wagner Paul A. (SEE REMARKS) on 2025-03-20
- Stock Option (right to buy): 920000 shares at $0 (D)

Inside Trans: Forte Biosciences, Inc. (FBRX) by Riley Antony A (CHIEF FINANCIAL OFFICER) on 2025-03-20
- Stock Option (right to buy): 323000 shares at $0 (D)

Inside Trans: Forte Biosciences, Inc. (FBRX) by Kornfeld Steven (Unknown Title) on 2025-03-20
- Stock Option (right to buy): 31000 shares at $0 (D)

Inside Trans: Forte Biosciences, Inc. (FBRX) by Brun Scott C. (Unknown Title) on 2025-03-20
- Stock Option (right to buy): 31000 shares at $0 (D)

Inside Trans: Forte Biosciences, Inc. (FBRX) by Doberstein Stephen K (Unknown Title) on 2025-03-20
- Stock Option (right to buy): 31000 shares at $0 (D)

Inside Trans: Forte Biosciences, Inc. (FBRX) by Kapoor Shivpreet Singh (Unknown Title) on 2025-03-20
- Stock Option (right to buy): 31000 shares at $0 (D)

Inside Trans: Forte Biosciences, Inc. (FBRX) by VINCENT RICHARD G (Unknown Title) on 2025-03-20
- Stock Option (right to buy): 31000 shares at $0 (D)

Inside Trans: Forte Biosciences, Inc. (FBRX) by GRYSKA DAVID W (Unknown Title) on 2025-03-20
- Stock Option (right to buy): 31000 shares at $0 (D)

Inside Trans: Forte Biosciences, Inc. (FBRX) by Wagner Paul A. (SEE REMARKS) on 2025-01-01
- Common Stock: 1250 shares at $0 (D)
- Common Stock: 164 shares at $22.71 (D)
- Restricted Stock Units: 1250 shares at $0 (D)

[Company Financial Summary]
[Company Details]
Name: Forte Biosciences, Inc. Common Stock
Market Cap: N/A
Shares Outstanding: N/A
Sector: PHARMACEUTICAL PREPARATIONS

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 1124000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -34195000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 7.56
Average Volume: 35631.05
30-Day High: 9.65
30-Day Low: 5.5

[Detailed Financials: Q3 2024]
- Total Assets: $17,946,000.0
- Total Liabilities: $8,580,000.0
- Total Equity: $9,366,000.0
- Current Assets: $17,668,000.0
- Current Liabilities: $8,580,000.0

[Income Statement: Q3 2024]
- Revenue: $0.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -4.54

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $-8,135,000.0

[Detailed Financials: Q2 2024]
- Total Assets: $26,078,000.0
- Total Liabilities: $-16,961,000.0
- Total Equity: $16,961,000.0
- Current Assets: $25,711,000.0
- Current Liabilities: $9,117,000.0

[Income Statement: Q2 2024]
- Revenue: $0.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.27

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $-5,946,000.0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

FBRX_OUT_17 [2025-03-25 11:04:48 -0400] 676 Bytes | 167 tokens | Cum: 3956 tkns (49.45% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

FBRX_IN_19 [2025-03-25 11:04:49 -0400] 126 Bytes | 29 tokens | Cum: 4013 tkns (50.16% of 8k)
==========================================================================

====================================
[2025-03-25 08:04:49] # Analysis Completed
Elapsed Time: 40.85 seconds